Cyclin-dependent kinase (CDK) 4/6 inhibitors in oncology
, und
05. Apr. 2020
Über diesen Artikel
Artikel-Kategorie: Editorial
Online veröffentlicht: 05. Apr. 2020
Seitenbereich: 1 - 1
DOI: https://doi.org/10.2478/fco-2019-0008
Schlüsselwörter
© 2019 Evangelos Karamitrousis et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
Karamitrousis, Evangelos
Department of Medical Oncology, Democritus University of ThraceAlexandroupolis, Greece
Liontos, Michalis
Department of Clinical Therapeutics, Alexandra HospitalAthens, Greece
Tsoukalas, Nikolaos
Department of Oncology, 401 General Military HospitalAthens, Greece